Resume

Providing strategic insights on ocular health, manufacturing, automation, business continuity and future trends for both manufacturing and products.

Capacity and business continuity oversight in the Manufacturing and Technology Organization with additional business administration responsibilities to support the $29.8Bn  spin-off of Alcon from Novartis.

Business Transformation Program Management — Assumed the management responsibilities of executing the terms and conditions of the Bi-Directional Manufacturing & Supply Agreement to ensure a smooth transition of manufacturing and supply operations.

• Developed the program strategies to manage the following deliverables: tech transfers, labeling change oversight, QC agreements, Regulatory agreements, Finance, IT, issue resolution, legal (IP), Sales and Operations Planning linkages, and delivery performance metrics.
• Managed the agreement for four years– resolved over 1000 open issues, recovered over $10M, completed tech transfer of 40 product families, and delivered multiple transitional service agreements on time and within budget.

Business Intelligence — Developed a BI tool to facilitate quarterly check-in with manufacturing and sales and provide a single source of truth based on manufacturing capacity data and commercial sales.

• Utilized Excel, pivot tables, Tableau, and a proprietary capacity analysis software to develop a heat-map outlook on possible capacity pinch points. The new process and tools helped identify and justify over $400M in investments to prevent lost sales.

Managed the global capacity and business continuity program, which included Pharma, Surgical, and Contact Lens franchises and 20 manufacturing sites. Introduced several tools to standardize processes and workflow across the manufacturing sites to build a robust risk mitigation and business continuity strategy.

Forecasting Tools – Standardized the capacity utilization review process to facilitate the rapid and accurate analysis of the annual five-year strategic sales outlook. The reporting tool offered stakeholders (manufacturing, Sales and Operations Planning, and the Commercial team) a single source of truth. In addition, it featured flexible inputs to enable “what if” scenarios providing cause-and-effect insights into market changes and equipment OEE impacts.

Global Standards — Updated the global policy with baseline expectations for all sites to provide a common standard for comparing performance and site capabilities to handle business disruptions to manufacturing.

• Developed a global reporting scorecard with site granularity and aggregation to each entity and identified risks in 3 areas– supplies, processes, and site redundancy. Since inception, process clarity has improved compliance, reduced complaints, and risk mitigation through dual sourcing YOY.

Lead the long term capacity planning process for the Vision Care, Surgical and Pharmaceutical franchises by integrating the commercial strategic plan with the manufacturing capacity outlook.

Projects include: flexible foil laminates, yield improvement, anti-counterfeiting, barcoding, package integrity testing, material validation, sterility testing, unique packaging solutions, vision systems, shrink wrapping, primary and secondary packaging, medical device packaging, molding, minitab modeling.

Installation and validation of molding and casting equipment for a Silicon Hydrogel toric lens. Developed the technology which became a published patent for UV mold pre-treatment enhancing lens comfort properties.